q0240 is a valid HCPCS code for 2023. It's used to specify:
Injection casirivimab and imdevimab 600 mg
q0240- HCPCS Details
Updated: May 23, 2023
HCPCS Code
q0240
Description
Short Description
Casirivi and imdevi 600 mg
Long Description
Injection casirivimab and imdevimab 600 mg
A code denoting Medicare coverage status.
HCPCS Coverage Code ⓘ
C
A code denoting the change made to a procedure or modifier code within the HCPCS system.
HCPCS Action Code ⓘ
N =
No maintenance for this code
Code used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.
HCPCS Pricing Indicator ⓘ
54 =
Vaccinations
Code used to identify instances where a procedure could be priced under multiple methodologies.
HCPCS Multiple Pricing Indicator Code ⓘ
A =
Not applicable as HCPCS priced under one methodology
Berenson-Eggers Type of Service (BETOS) classification categories are used to analyze Medicare costs. All Health Care Financing Administration Common Procedure Coding System (HCPCS) procedure codes are assigned to a BETOS category.
BETOS Classification ⓘ
O1G =
Immunizations/Vaccinations
The carrier assigned CMS type of service which describes the particular kind(s) of service represented by the procedure code.
Type of Service ⓘ
V =
( )
Effective date of action to a procedure or modifier code
Effective Date ⓘ
07/30/2021
The year the HCPCS code was added to the Healthcare Common Procedure Coding System.
Date Added ⓘ
07/30/2021
Termination Date
-
The HCPCS Code Section that this code belongs to. It's typically denoted by the first letter in the code.
